Affiliation
University of Birmingham; University Hospitals Birmingham NHS Foundation Trust; Dana-Farber Cancer Institute; Broad Institute of MIT and Harvard; Harvard Medical School; Brigham and Women's HospitalPublication date
2020-12-17
Metadata
Show full item recordAbstract
Cancer vaccine development has been historically fraught with difficulty, but tremendous progress has been made over the past 5 years. In this In Focus article, we reflect on the progress and challenges with vaccine development for cancers in general and for hematologic malignancies in particular, and suggest how our cancer vaccine experience can offer insight into COVID-19 vaccination.Citation
Kwok M, Fritsch EF, Wu CJ. Cancer and COVID-19: On the Quest for Effective Vaccines. Blood Cancer Discov. 2021 Jan;2(1):13-18. doi: 10.1158/2643-3230.BCD-20-0205. Epub 2020 Dec 17.Type
ArticleAdditional Links
https://aacrjournals.org/bloodcancerdiscovPMID
35015661Journal
Blood Cancer DiscoveryPublisher
American Association for Cancer Researchae974a485f413a2113503eed53cd6c53
10.1158/2643-3230.BCD-20-0205